403 related articles for article (PubMed ID: 11245451)
1. Randomized trial of supplemental beta-carotene to prevent second head and neck cancer.
Mayne ST; Cartmel B; Baum M; Shor-Posner G; Fallon BG; Briskin K; Bean J; Zheng T; Cooper D; Friedman C; Goodwin WJ
Cancer Res; 2001 Feb; 61(4):1457-63. PubMed ID: 11245451
[TBL] [Abstract][Full Text] [Related]
2. Supplemental beta-carotene, smoking, and urinary F2-isoprostane excretion in patients with prior early stage head and neck cancer.
Mayne ST; Walter M; Cartmel B; Goodwin WJ; Blumberg J
Nutr Cancer; 2004; 49(1):1-6. PubMed ID: 15454352
[TBL] [Abstract][Full Text] [Related]
3. A randomized trial of antioxidant vitamins to prevent second primary cancers in head and neck cancer patients.
Bairati I; Meyer F; Gélinas M; Fortin A; Nabid A; Brochet F; Mercier JP; Têtu B; Harel F; Mâsse B; Vigneault E; Vass S; del Vecchio P; Roy J
J Natl Cancer Inst; 2005 Apr; 97(7):481-8. PubMed ID: 15812073
[TBL] [Abstract][Full Text] [Related]
4. Randomized phase III trial of low-dose isotretinoin for prevention of second primary tumors in stage I and II head and neck cancer patients.
Khuri FR; Lee JJ; Lippman SM; Kim ES; Cooper JS; Benner SE; Winn R; Pajak TF; Williams B; Shenouda G; Hodson I; Fu K; Shin DM; Vokes EE; Feng L; Goepfert H; Hong WK
J Natl Cancer Inst; 2006 Apr; 98(7):441-50. PubMed ID: 16595780
[TBL] [Abstract][Full Text] [Related]
5. beta-carotene supplementation in patients radically treated for stage I-II head and neck cancer: results of a randomized trial.
Toma S; Bonelli L; Sartoris A; Mira E; Antonelli A; Beatrice F; Giordano C; Benazzo M; Caroggio A; Cavalot AL; Gandolfo S; Garozzo A; Margarino G; Schenone G; Spadini N; Zibordi F; Balzarini F; Serafini I; Miani P; Cortesina G
Oncol Rep; 2003; 10(6):1895-901. PubMed ID: 14534715
[TBL] [Abstract][Full Text] [Related]
6. The impact of smoking status, disease stage, and index tumor site on second primary tumor incidence and tumor recurrence in the head and neck retinoid chemoprevention trial.
Khuri FR; Kim ES; Lee JJ; Winn RJ; Benner SE; Lippman SM; Fu KK; Cooper JS; Vokes EE; Chamberlain RM; Williams B; Pajak TF; Goepfert H; Hong WK
Cancer Epidemiol Biomarkers Prev; 2001 Aug; 10(8):823-9. PubMed ID: 11489748
[TBL] [Abstract][Full Text] [Related]
7. Randomized trial of antioxidant vitamins to prevent acute adverse effects of radiation therapy in head and neck cancer patients.
Bairati I; Meyer F; Gélinas M; Fortin A; Nabid A; Brochet F; Mercier JP; Têtu B; Harel F; Abdous B; Vigneault E; Vass S; Del Vecchio P; Roy J
J Clin Oncol; 2005 Aug; 23(24):5805-13. PubMed ID: 16027437
[TBL] [Abstract][Full Text] [Related]
8. Chemoprevention of head and neck cancer with retinoids: a negative result.
Perry CF; Stevens M; Rabie I; Yarker ME; Cochrane J; Perry E; Traficante R; Coman W
Arch Otolaryngol Head Neck Surg; 2005 Mar; 131(3):198-203. PubMed ID: 15781758
[TBL] [Abstract][Full Text] [Related]
9. The Beta-Carotene and Retinol Efficacy Trial: incidence of lung cancer and cardiovascular disease mortality during 6-year follow-up after stopping beta-carotene and retinol supplements.
Goodman GE; Thornquist MD; Balmes J; Cullen MR; Meyskens FL; Omenn GS; Valanis B; Williams JH
J Natl Cancer Inst; 2004 Dec; 96(23):1743-50. PubMed ID: 15572756
[TBL] [Abstract][Full Text] [Related]
10. Beta-carotene supplementation for patients with low baseline levels and decreased risks of total and prostate carcinoma.
Cook NR; Stampfer MJ; Ma J; Manson JE; Sacks FM; Buring JE; Hennekens CH
Cancer; 1999 Nov; 86(9):1783-92. PubMed ID: 10547552
[TBL] [Abstract][Full Text] [Related]
11. Occurrence of other cancers among patients with prior basal cell and squamous cell skin cancer.
Karagas MR; Greenberg ER; Mott LA; Baron JA; Ernster VL
Cancer Epidemiol Biomarkers Prev; 1998 Feb; 7(2):157-61. PubMed ID: 9488591
[TBL] [Abstract][Full Text] [Related]
12. The effect of folic acid on the development of stomach and other gastrointestinal cancers.
Zhu S; Mason J; Shi Y; Hu Y; Li R; Wahg M; Zhou Y; Jin G; Xie Y; Wu G; Xia D; Qian Z; Sohg H; Zhang L; Russell R; Xiao S
Chin Med J (Engl); 2003 Jan; 116(1):15-9. PubMed ID: 12667380
[TBL] [Abstract][Full Text] [Related]
13. Prevention of second primary tumors with isotretinoin in squamous-cell carcinoma of the head and neck.
Hong WK; Lippman SM; Itri LM; Karp DD; Lee JS; Byers RM; Schantz SP; Kramer AM; Lotan R; Peters LJ
N Engl J Med; 1990 Sep; 323(12):795-801. PubMed ID: 2202902
[TBL] [Abstract][Full Text] [Related]
14. An apple a day...does it really keep the doctor away? The current state of cancer chemoprevention.
Kim ES; Hong WK
J Natl Cancer Inst; 2005 Apr; 97(7):468-70. PubMed ID: 15812064
[No Abstract] [Full Text] [Related]
15. Acute adverse effects of radiation therapy and local recurrence in relation to dietary and plasma beta carotene and alpha tocopherol in head and neck cancer patients.
Meyer F; Bairati I; Jobin E; Gélinas M; Fortin A; Nabid A; Têtu B
Nutr Cancer; 2007; 59(1):29-35. PubMed ID: 17927499
[TBL] [Abstract][Full Text] [Related]
16. A clinical trial of beta carotene to prevent basal-cell and squamous-cell cancers of the skin. The Skin Cancer Prevention Study Group.
Greenberg ER; Baron JA; Stukel TA; Stevens MM; Mandel JS; Spencer SK; Elias PM; Lowe N; Nierenberg DW; Bayrd G
N Engl J Med; 1990 Sep; 323(12):789-95. PubMed ID: 2202901
[TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of cyclooxygenase-2 overexpression in glottic cancer.
Sackett MK; Bairati I; Meyer F; Jobin E; Lussier S; Fortin A; Gélinas M; Nabid A; Brochet F; Têtu B
Clin Cancer Res; 2008 Jan; 14(1):67-73. PubMed ID: 18172254
[TBL] [Abstract][Full Text] [Related]
18. Lack of effect of daily N-acetylcysteine supplementation on mutagen sensitivity.
Cloos J; Bongers V; Lubsen H; Tobi H; Braakhuis BJ; Snow GB
Cancer Epidemiol Biomarkers Prev; 1996 Nov; 5(11):941-4. PubMed ID: 8922306
[TBL] [Abstract][Full Text] [Related]
19. [Prevention of second primary cancer with vitamin supplementation in patients treated for head and neck cancers].
Bairati I; Brochet F; Roy J; Gélinas M; Nabid A; Têtu B; Mâsse B; Meyer F
Bull Cancer Radiother; 1996; 83(1):12-6. PubMed ID: 8679274
[TBL] [Abstract][Full Text] [Related]
20. Chemoprevention of precancerous gastric lesions with antioxidant vitamin supplementation: a randomized trial in a high-risk population.
Plummer M; Vivas J; Lopez G; Bravo JC; Peraza S; Carillo E; Cano E; Castro D; Andrade O; Sánchez V; Garcia R; Buiatti E; Aebischer C; Franceschi S; Oliver W; Muñoz N
J Natl Cancer Inst; 2007 Jan; 99(2):137-46. PubMed ID: 17227997
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
